Business Description
OKYO Pharma Ltd
ISIN : GG00BMFG5F62
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | -3.82 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -18.2 | |||||
3-Year EPS without NRI Growth Rate | -21.3 | |||||
3-Year FCF Growth Rate | -27.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 62.64 | |||||
9-Day RSI | 61.77 | |||||
14-Day RSI | 59.56 | |||||
6-1 Month Momentum % | -32.52 | |||||
12-1 Month Momentum % | -40.71 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.21 | |||||
Quick Ratio | 0.21 | |||||
Cash Ratio | 0.11 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -47.7 | |||||
Shareholder Yield % | -22.19 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -393.54 | |||||
ROIC % | -1184.28 | |||||
3-Year ROIIC % | 9206.95 | |||||
ROC (Joel Greenblatt) % | -263740 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -3.09 | |||||
EV-to-Forward-EBIT | -1.56 | |||||
EV-to-EBITDA | -3.09 | |||||
EV-to-FCF | -5.3 | |||||
Earnings Yield (Greenblatt) % | -32.36 | |||||
FCF Yield % | -18.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
OKYO Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.154 | ||
Beta | 0 | ||
Volatility % | 39.7 | ||
14-Day RSI | 59.56 | ||
14-Day ATR (€) | 0.064547 | ||
20-Day SMA (€) | 0.90025 | ||
12-1 Month Momentum % | -40.71 | ||
52-Week Range (€) | 0.755 - 1.88 | ||
Shares Outstanding (Mil) | 33.84 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
OKYO Pharma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
OKYO Pharma Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
OKYO Pharma Ltd Frequently Asked Questions
What is OKYO Pharma Ltd(STU:OK10)'s stock price today?
When is next earnings date of OKYO Pharma Ltd(STU:OK10)?
Does OKYO Pharma Ltd(STU:OK10) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |